InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,570.79
(
0.06%
)
US TECH 100
19,887.60
(
0.21%
)
Dow Jones
39,349.20
(
-0.07%
)
Brent Oil
85.46
(
-1.21%
)
Bitcoin
56,196.34
(
0.63%
)
Post# of 40502
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

mackwheaton

Send PM Follow Ignore
Followers 28
Posts 1057
Boards Moderated 1
Alias Born 04/08/2011

mackwheaton

Re: None

Saturday, 07/27/2013 10:54:18 PM

Saturday, July 27, 2013 10:54:18 PM

Post# of 40502
One in nine drugs make it from Phase I to approval. Lead indications are one in seven, secondary indications one in 30. Sobering information. I think 39 drugs were approved in 2012. So it is a long road we travel, knowing that 8 of 9 do not reach the finish line. I would love some encouragement for why we should expect better, but ultimately that too will have to be tempered by the number of synthetic DNA approvals are on the books.
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Detailed Quote
Recent INO News
More INO News
InvestorsHub NewsWire

Glidelogic Corp. Becomes TikTok Shop Partner, Opening a New Chapter in E-commerce Services • GDLG • Jul 5, 2024 7:09 AM

Freedom Holdings Corporate Update; Announces Management Has Signed Letter of Intent • FHLD • Jul 3, 2024 9:00 AM

EWRC's 21 Moves Gaming Studios Moves to SONY Pictures Studios and Green Lights Development of a Third Upcoming Game • EWRC • Jul 2, 2024 8:00 AM

BNCM and DELEX Healthcare Group Announce Strategic Merger to Drive Expansion and Growth • BNCM • Jul 2, 2024 7:19 AM

NUBURU Announces Upcoming TV Interview Featuring CEO Brian Knaley on Fox Business, Bloomberg TV, and Newsmax TV as Sponsored Programming • BURU • Jul 1, 2024 1:57 PM

Mass Megawatts Announces $220,500 Debt Cancellation Agreement to Improve Financing and Sales of a New Product to be Announced on July 11 • MMMW • Jun 28, 2024 7:30 AM

Start posting your company's news
Only $200 per official company press release!